Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56026 - 56050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	CORO2A	7464	upregulated	panobinostat results in increased expression of CORO2A mRNA	9q22.33	A21037
Panobinostat	Approved Investigational	CPE	1363	upregulated	panobinostat results in increased expression of CPE mRNA	4q32.3	A21037
Panobinostat	Approved Investigational	CPED1	79974	upregulated	panobinostat results in increased expression of CPED1 mRNA	7q31.31	A21037
Panobinostat	Approved Investigational	CPNE4	131034	upregulated	panobinostat results in increased expression of CPNE4 mRNA	3q22.1	A21037
Panobinostat	Approved Investigational	CPXM2	119587	upregulated	panobinostat results in increased expression of CPXM2 mRNA	10q26.13	A21037
Panobinostat	Approved Investigational	CR1L	1379	upregulated	panobinostat results in increased expression of CR1L mRNA	1q32.2	A21037
Panobinostat	Approved Investigational	CR2	1380	upregulated	panobinostat results in increased expression of CR2 mRNA	1q32.2	A21037
Panobinostat	Approved Investigational	CRABP2	1382	upregulated	panobinostat results in increased expression of CRABP2 mRNA	1q23.1	A21037
Panobinostat	Approved Investigational	CRISPLD1	83690	upregulated	panobinostat results in increased expression of CRISPLD1 mRNA	8q21.13	A21037
Panobinostat	Approved Investigational	CRYBA1	1411	downregulated	panobinostat results in decreased expression of CRYBA1 mRNA	17q11.2	A21037
Panobinostat	Approved Investigational	CRYBA4	1413	downregulated	panobinostat results in decreased expression of CRYBA4 mRNA	22q12.1	A21037
Panobinostat	Approved Investigational	CSPG5	10675	downregulated	panobinostat results in decreased expression of CSPG5 mRNA	3p21.31	A21037
Panobinostat	Approved Investigational	CTNND2	1501	downregulated	panobinostat results in decreased expression of CTNND2 mRNA	5p15.2	A21037
Panobinostat	Approved Investigational	CUL3	8452	downregulated	panobinostat results in decreased expression of CUL3 mRNA	2q36.2	A21037
Panobinostat	Approved Investigational	CX3CL1	6376	upregulated	panobinostat results in increased expression of CX3CL1 mRNA	16q21	A21037
Panobinostat	Approved Investigational	CXCL12	6387	upregulated	panobinostat results in increased expression of CXCL12 mRNA	10q11.21	A21037
Panobinostat	Approved Investigational	CXCL14	9547	upregulated	panobinostat results in increased expression of CXCL14 mRNA	5q31.1	A21037
Panobinostat	Approved Investigational	CXCL5	6374	upregulated	panobinostat results in increased expression of CXCL5 mRNA	4q13.3	A21037
Panobinostat	Approved Investigational	CXXC5	51523	upregulated	panobinostat results in increased expression of CXXC5 mRNA	5q31.2	A21037
Panobinostat	Approved Investigational	CYP1A1	1543	upregulated	panobinostat results in increased expression of CYP1A1 mRNA	15q24.1	A21037
Panobinostat	Approved Investigational	CYP1B1	1545	upregulated	panobinostat results in increased expression of CYP1B1 mRNA	2p22.2	A21037
Panobinostat	Approved Investigational	DAB1	1600	downregulated	panobinostat results in decreased expression of DAB1 mRNA	1p32.2	A21037
Panobinostat	Approved Investigational	DACH2	117154	upregulated	panobinostat results in increased expression of DACH2 mRNA	Xq21.2	A21037
Panobinostat	Approved Investigational	DACT1	51339	upregulated	panobinostat results in increased expression of DACT1 mRNA	14q23.1	A21037
Panobinostat	Approved Investigational	DAZL	1618	downregulated	panobinostat results in decreased expression of DAZL mRNA	3p24.3	A21037

Displaying entries 56026 - 56050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability